
CLINICAL EVIDENCE THE EVRA STUDY
A randomized trial of early endovenous ablation in venous ulceration.1
Sign up to connect with us
EARLY ENDOVENOUS ABLATION TREATMENT MATTERS
In the EVRA study, venous leg ulcer patients treated with early endovenous ablation combined with compression therapy, when compared to delayed endovenous treatment, experienced1:
- Significantly shorter time to healing
- Extended time free from ulcers

EVRA STUDY FINDINGS
As published in the New England Journal of Medicine
32% faster ulcer healing time in the early treatment group1
56 DAYS median time to ulcer healing, compared to 82 in the control group1
28 DAYS more ulcer-free time during the first year in the early treatment group1
The EVRA study was a multicenter, randomized clinical trial of 450 patients.
EXPERIENCE OUR CVI PORTFOLIO ADVANTAGE
Our comprehensive CVI toolkit empowers you to select the best approach for each patient.
Explore Products
VenaSeal™ Closure System

ClosureFast™ Radiofrequency Ablation System
Reference
1
Gohel MS, Heatley F, Liu X, et al. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration. N Engl J Med. May 31, 2018;378(22)2105-2114.